01/04/2021
https://www.msnbc.com...
"The CBO, as we know, expects this legislation would accelerate the availability of generic drugs and save $4.7 billion over 10 years."
"You have an FTC which probably does not have the resources to match yours and the pharmaceutical industry."
"Many more cases settle without pay-for-delay than with pay-for-delay."
"What incentive do they have not to do it?"